N. V. Kanishcheva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
N. V. Kanishcheva has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- D. V. Sikorsky
Nizhny Novgorod Regional Clinical Oncologic Dispensary
4 shared publications D. V. Skamnitsky
Nizhny Novgorod Regional Clinical Oncologic Dispensary
3 shared publications- K. V. Bazanov
Nizhny Novgorod Regional Clinical Oncologic Dispensary
2 shared publications S. O. Podvyaznikov
Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia
2 shared publications- A. M. Ermolaeva
Nizhny Novgorod Regional Clinical Oncologic Dispensary
1 shared publication - A. N. Volodin
Scientific Research Institute, Clinical Oncology, Nizhny Novgorod Regional Clinical Oncological Dispensary
1 shared publication
Latest Publications
- Open Access
- 9 June 2026
- Published by Publishing House ABV Press in Head and Neck Tumors (HNT)
- Vol. 16 (1) , 38-54
Combination treatment with glossectomy, laryngectomy and subtotal mandibulectomy in patients after unsuccessful treatment of locally advanced cancer of the oral mucosa
Introduction. Despite the advancements in science and technology, results of antitumor treatment of recurrent oral squamous cell carcinoma (rOSCC) remain unsatisfactory: patient survival is very low. In cases of recurrent disease, single-step glossectomy, subtotal segmental mandibulectomy and laryngectomy are feasible. Aim. To analyze the results of combination surgical treatment of rOSCC using glossectomy, subtotal segmental mandibulectomy and laryngectomy after previous unsuccessful antitumor treatment to improve outcomes of treatment of recurrences and continued growth of locally advanced cancer. Materials and methods. Single-center prospective study was conducted. It included patients with recurrent squamous cell carcinoma of the oral mucosa and larynx with indications for antitumor treatment using multicomponent surgical intervention in the framework of comprehensive treatment. The case of the treatment of recurrent laryngeal cancer served as a prototype for the development of techniques for simultaneous glosectomy, segmental resection of the mandible and laryngectomy. Two patients had malignant neoplasms of the oral mucosa: in one case, stage рT3N0M0 III tongue cancer, condition after hemiglossectomy, level I–II–III cervical lymph node dissection and radiotherapy; in the other case, stage рT3N0M0 III rOSCC after radiation therapy. Results. During surgery, skin resection was performed above the tumor component of the submandibular area due to signs of derma invasion and danger of penetrating growth with intradermal dissemination caused by postradiation edema. For defect reconstruction, in 1 patient with laryngeal cancer and 1 patient with rOSCC, pectoralis major myocutaneous flap was used. In 1 case of rOSCC, due to rapid wight loss during radiation therapy, primary reconstruction with pharyngostomy formation with total defect of the tongue, mandible and larynx was not performed. Local purulent and necrotic postoperative complications were observed in all 3 patients. In the first 30 days after the surgery, 1 patient with rOSCC died at the hospital; 30-day mortality after combination surgeries was 33 %. Another patient with rOSCC died 2.5 months after discharge, a little more than 90 days (3.5 months) after the surgery. The patient with laryngeal cancer is currently alive without signs of disease. Conclusion. The surgical interventions described are life-saving surgeries due to exhausted capabilities of radiation therapy, supposed low efficacy of antitumor drug therapy in the presence of a mass of crumbling tissues.
- 9 June 2026
- Published by Publishing House ABV Press in Head and Neck Tumors (HNT)
- Vol. 16 (1) , 38-54
Open AccessCombination treatment with glossectomy, laryngectomy and subtotal mandibulectomy in patients after unsuccessful treatment of locally advanced cancer of the oral mucosa
Introduction. Despite the advancements in science and technology, results of antitumor treatment of recurrent oral squamous cell carcinoma (rOSCC) remain unsatisfactory: patient survival is very low. In cases of recurrent disease, single-step glossectomy, subtotal segmental mandibulectomy and laryngectomy are feasible. Aim. To analyze the results of combination surgical treatment of rOSCC using glossectomy, subtotal segmental mandibulectomy and laryngectomy after previous unsuccessful antitumor treatment to improve outcomes of treatment of recurrences and continued growth of locally advanced cancer. Materials and methods. Single-center prospective study was conducted. It included patients with recurrent squamous cell carcinoma of the oral mucosa and larynx with indications for antitumor treatment using multicomponent surgical intervention in the framework of comprehensive treatment. The case of the treatment of recurrent laryngeal cancer served as a prototype for the development of techniques for simultaneous glosectomy, segmental resection of the mandible and laryngectomy. Two patients had malignant neoplasms of the oral mucosa: in one case, stage рT3N0M0 III tongue cancer, condition after hemiglossectomy, level I–II–III cervical lymph node dissection and radiotherapy; in the other case, stage рT3N0M0 III rOSCC after radiation therapy. Results. During surgery, skin resection was performed above the tumor component of the submandibular area due to signs of derma invasion and danger of penetrating growth with intradermal dissemination caused by postradiation edema. For defect reconstruction, in 1 patient with laryngeal cancer and 1 patient with rOSCC, pectoralis major myocutaneous flap was used. In 1 case of rOSCC, due to rapid wight loss during radiation therapy, primary reconstruction with pharyngostomy formation with total defect of the tongue, mandible and larynx was not performed. Local purulent and necrotic postoperative complications were observed in all 3 patients. In the first 30 days after the surgery, 1 patient with rOSCC died at the hospital; 30-day mortality after combination surgeries was 33 %. Another patient with rOSCC died 2.5 months after discharge, a little more than 90 days (3.5 months) after the surgery. The patient with laryngeal cancer is currently alive without signs of disease. Conclusion. The surgical interventions described are life-saving surgeries due to exhausted capabilities of radiation therapy, supposed low efficacy of antitumor drug therapy in the presence of a mass of crumbling tissues.
- Open Access
- 10 April 2020
- Published by Publishing House ABV Press in Head and Neck Tumors (HNT)
- Vol. 10 (1) , 38-46-46
Total glossectomy in multimodal treatment of oropharyngeal cancer: immediate results
The study objective is to analyze the results of combined antitumor therapy, which included glossectomy, to treat locally advanced and recurrent oropharyngeal squamous cell cancer.Materials and methods. We performed a retrospective analysis of multimodal antitumor therapy of 19 patients, who were treated in the Nizhny Novgorod Regional Clinical Oncologic Dispensary within 2009–2019. All patients underwent segmental resection of the mandible due to massive tumor invasion into the periosteum. After total glossectomy the defect was filled using pectoralis musculocutaneous flap. Due to the wide local tumor spread, a neck dissection (n = 7) or radical cervical lymphadenectomy (n = 12) were performed. During preventive surgery, metastases that were not detected before surgery were revealed in 2 patients in 1 neck lymph node. Results. Eleven patients had local purulent-necrotic postoperative complications. It was noted that after surgery but without radiation therapy complications developed in fewer patients (n = 4) and were less severe: of I degree – in 3 patients, of III degree – in 1 patient. Radiation therapy before surgery resulted in more severe purulent-necrotic complications in 7 patients: of I degree – in 2 patients, of II degree – in 1, of III degree – in 4. Mortality rates: 30-day, 60-day and 90-day – 10.5 %, 21 % and 37 %, respectively. The causes of death were complications of gastrostomy: profuse bleeding from the stomach wall (n = 1), acute psychosis complicated by cerebral edema (n = 1), increased heart failure (n = 1), necrosis of the anterior abdominal wall and cachexia, developed after gastrostomy (n = 1), continued tumor growth between chemotherapy courses (n = 3). Twelve patients survived more than 90 days after surgery, 3 patients – more than 2 years. As most of the patients could not swallow, they were administered a nasogastric tube, since a simultaneous gastrostomy increases the duration of a traumatic operation and aggravates the postoperative period.Conclusion. Multicomponent surgery after radiation therapy results in more often local purulent-necrotic postoperative complications than if the surgery is performed before radiation therapy. High mortality in the first 90 days after surgery (n = 7) due to local cancer spread is generally determined by the severe condition of patients with advanced cancer and the concomitant diseases. However, rejection of gastrostomy in favor of nasogastric tube seems reasonable, since several deaths in the early postoperative period may be occurred due to complications associated with gastrostomy.
- 10 April 2020
- Published by Publishing House ABV Press in Head and Neck Tumors (HNT)
- Vol. 10 (1) , 38-46-46
Open AccessTotal glossectomy in multimodal treatment of oropharyngeal cancer: immediate results
The study objective is to analyze the results of combined antitumor therapy, which included glossectomy, to treat locally advanced and recurrent oropharyngeal squamous cell cancer.Materials and methods. We performed a retrospective analysis of multimodal antitumor therapy of 19 patients, who were treated in the Nizhny Novgorod Regional Clinical Oncologic Dispensary within 2009–2019. All patients underwent segmental resection of the mandible due to massive tumor invasion into the periosteum. After total glossectomy the defect was filled using pectoralis musculocutaneous flap. Due to the wide local tumor spread, a neck dissection (n = 7) or radical cervical lymphadenectomy (n = 12) were performed. During preventive surgery, metastases that were not detected before surgery were revealed in 2 patients in 1 neck lymph node. Results. Eleven patients had local purulent-necrotic postoperative complications. It was noted that after surgery but without radiation therapy complications developed in fewer patients (n = 4) and were less severe: of I degree – in 3 patients, of III degree – in 1 patient. Radiation therapy before surgery resulted in more severe purulent-necrotic complications in 7 patients: of I degree – in 2 patients, of II degree – in 1, of III degree – in 4. Mortality rates: 30-day, 60-day and 90-day – 10.5 %, 21 % and 37 %, respectively. The causes of death were complications of gastrostomy: profuse bleeding from the stomach wall (n = 1), acute psychosis complicated by cerebral edema (n = 1), increased heart failure (n = 1), necrosis of the anterior abdominal wall and cachexia, developed after gastrostomy (n = 1), continued tumor growth between chemotherapy courses (n = 3). Twelve patients survived more than 90 days after surgery, 3 patients – more than 2 years. As most of the patients could not swallow, they were administered a nasogastric tube, since a simultaneous gastrostomy increases the duration of a traumatic operation and aggravates the postoperative period.Conclusion. Multicomponent surgery after radiation therapy results in more often local purulent-necrotic postoperative complications than if the surgery is performed before radiation therapy. High mortality in the first 90 days after surgery (n = 7) due to local cancer spread is generally determined by the severe condition of patients with advanced cancer and the concomitant diseases. However, rejection of gastrostomy in favor of nasogastric tube seems reasonable, since several deaths in the early postoperative period may be occurred due to complications associated with gastrostomy.
- Open Access
- 7 December 2019
- Published by Publishing House ABV Press in Head and Neck Tumors (HNT)
- Vol. 9 (4)
Conformal radiotherapy in combination with cetuximab for stage Т1–2 tongue cancer with N1–2b regional metastases detected after preventive lymphadenectomy
The study objective is to analyze the experience of conformal radiotherapy in combination with cetuximab for cervical lymph node (LN) metastasis in patients with early-stage tongue cancer who had undergone multicomponent surgeries.Materials and methods. This retrospective study included 48 patients with primary squamous cell carcinoma of the tongue (Т1–2) that were treated in Nizhny Novgorod Regional Clinical Oncology Dispensary between 2012 and 2019. The experimental group comprised 25 patients who underwent hemiglossectomy with simultaneous preventive cervical lymph node dissection. The control group was composed of 23 patients who underwent hemiglossectomy alone due to the presence of concomitant somatic pathology. Before surgery, none of the patients had any signs of metastatic lesions in the cervical LNs according to the results of clinical and instrumental examinations. After surgery, 100 % of patients from the experimental group were found to have N1–2b cervical LN metastases at histological examination. Patients from the control group developed clinical signs of cervical LN metastasis within a year after operation. All patients underwent radiotherapy. The experimental group was divided into two subgroups: patients from subgroup 1 (n = 11) received cetuximab due to disease progression, whereas patients from subgroup 2 (n = 14) received cisplatin. Participants from the control group received no chemotherapy due to their concomitant somatic disorders and because regional metastasis was not confirmed.Results. In the control group, the time between surgery and patient’s death varied between 8 and 14 months. Patients from subgroups 1 and 2 survived for 12–60 months and 8–48 months respectively. So far, 9 patients from subgroup 1 and 6 patients from subgroup 2 are alive. Among them, 8 participants from subgroup 1 and 4 participants from subgroup 2 have no signs of disease progression. Three patients from subgroup 2 died of cardiovascular diseases (they had no cancer progression within 3 months after the completion of chemotherapy).Conclusion. Preventive lymph node dissection in patients with stage Т1–2 tongue cancer enables early detection of subclinical N1–2b metastases and ensures timely initiation of therapy. Our experience confirmed safety of cetuximab plus radiotherapy used to improve disease control and increase patient’s survival.
- 7 December 2019
- Published by Publishing House ABV Press in Head and Neck Tumors (HNT)
- Vol. 9 (4)
Open AccessConformal radiotherapy in combination with cetuximab for stage Т1–2 tongue cancer with N1–2b regional metastases detected after preventive lymphadenectomy
The study objective is to analyze the experience of conformal radiotherapy in combination with cetuximab for cervical lymph node (LN) metastasis in patients with early-stage tongue cancer who had undergone multicomponent surgeries.Materials and methods. This retrospective study included 48 patients with primary squamous cell carcinoma of the tongue (Т1–2) that were treated in Nizhny Novgorod Regional Clinical Oncology Dispensary between 2012 and 2019. The experimental group comprised 25 patients who underwent hemiglossectomy with simultaneous preventive cervical lymph node dissection. The control group was composed of 23 patients who underwent hemiglossectomy alone due to the presence of concomitant somatic pathology. Before surgery, none of the patients had any signs of metastatic lesions in the cervical LNs according to the results of clinical and instrumental examinations. After surgery, 100 % of patients from the experimental group were found to have N1–2b cervical LN metastases at histological examination. Patients from the control group developed clinical signs of cervical LN metastasis within a year after operation. All patients underwent radiotherapy. The experimental group was divided into two subgroups: patients from subgroup 1 (n = 11) received cetuximab due to disease progression, whereas patients from subgroup 2 (n = 14) received cisplatin. Participants from the control group received no chemotherapy due to their concomitant somatic disorders and because regional metastasis was not confirmed.Results. In the control group, the time between surgery and patient’s death varied between 8 and 14 months. Patients from subgroups 1 and 2 survived for 12–60 months and 8–48 months respectively. So far, 9 patients from subgroup 1 and 6 patients from subgroup 2 are alive. Among them, 8 participants from subgroup 1 and 4 participants from subgroup 2 have no signs of disease progression. Three patients from subgroup 2 died of cardiovascular diseases (they had no cancer progression within 3 months after the completion of chemotherapy).Conclusion. Preventive lymph node dissection in patients with stage Т1–2 tongue cancer enables early detection of subclinical N1–2b metastases and ensures timely initiation of therapy. Our experience confirmed safety of cetuximab plus radiotherapy used to improve disease control and increase patient’s survival.
- Open Access
- 3 April 2019
- Published by Publishing House ABV Press in Head and Neck Tumors (HNT)
- Vol. 9 (1) , 74-78
Postoperative conformal radiotherapy of locally advanced squamous-cell oropharyngeal cancer
The study objective is to demonstrate the necessity of individual selection of radiation plan in patients with locally advanced squamous-cell oropharyngeal cancer after multicomponent operation to decrease radioreactions and radiation injuries.Materials and methods. The study included data on 64 patients with primary locally advanced oropharyngeal cancer after combination treatment at the Nizhny Novgorod Regional Clinical Oncological Dispensary in 2013–2018. Radiation treatment was performed after surgeries. The 1st group included 30 patients who underwent conformal radiation using linear accelerators. The 2nd group included 34 patients who underwent conventional radiation.Results. For conformal radiotherapy, grade I mucositis was observed in 2 (6.6 %) patients, grade II – in 25 (83.4 %) patients, grade III– IV – in 3 (10 %) patients. In the 1st group, radioreactions developed at dose 30 Gy, in the 2nd group at 20 Gy. In the 2nd group, radioreactions were more severe. Grade II mucositis after conventional radiation were observed in 21 (61.7 %) patients, grade III–IV – in 13 (38.3 %) patients, among them 8 (23.5%) received split-course radiotherapy. Partial necrosis of the flap was detected in 1 (3.3 %) patient in the 1st group and in 4 (2.9 %) patients in the 2nd group.Conclusion. Conformal radiotherapy, including modulated intensity, is characterized by better isodose distribution with minimal effect on the surrounding healthy tissue and vascular pedicle of the transplant after multicomponent operations. This type of radiation allows to decrease the risk of radioreactions and complications requiring expensive accompanying therapy or even split-course treatment.
- 3 April 2019
- Published by Publishing House ABV Press in Head and Neck Tumors (HNT)
- Vol. 9 (1) , 74-78
Open AccessPostoperative conformal radiotherapy of locally advanced squamous-cell oropharyngeal cancer
The study objective is to demonstrate the necessity of individual selection of radiation plan in patients with locally advanced squamous-cell oropharyngeal cancer after multicomponent operation to decrease radioreactions and radiation injuries.Materials and methods. The study included data on 64 patients with primary locally advanced oropharyngeal cancer after combination treatment at the Nizhny Novgorod Regional Clinical Oncological Dispensary in 2013–2018. Radiation treatment was performed after surgeries. The 1st group included 30 patients who underwent conformal radiation using linear accelerators. The 2nd group included 34 patients who underwent conventional radiation.Results. For conformal radiotherapy, grade I mucositis was observed in 2 (6.6 %) patients, grade II – in 25 (83.4 %) patients, grade III– IV – in 3 (10 %) patients. In the 1st group, radioreactions developed at dose 30 Gy, in the 2nd group at 20 Gy. In the 2nd group, radioreactions were more severe. Grade II mucositis after conventional radiation were observed in 21 (61.7 %) patients, grade III–IV – in 13 (38.3 %) patients, among them 8 (23.5%) received split-course radiotherapy. Partial necrosis of the flap was detected in 1 (3.3 %) patient in the 1st group and in 4 (2.9 %) patients in the 2nd group.Conclusion. Conformal radiotherapy, including modulated intensity, is characterized by better isodose distribution with minimal effect on the surrounding healthy tissue and vascular pedicle of the transplant after multicomponent operations. This type of radiation allows to decrease the risk of radioreactions and complications requiring expensive accompanying therapy or even split-course treatment.